Amedisys (AMED) Tops Q1 EPS by 11c

Amedisys (NASDAQ: AMED) reported Q1 EPS of $0.31, $0.11 better than the analyst estimate of $0.20. Revenue for the quarter came in at $301.6 million versus the consensus estimate of $300.17 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Cloudastructure restructures preferred stock, issues $1.3M promissory note
• Morgan Stanley Resumes Victoria Secret (VSXY) at Overweight